MENU

SLXN Silexion Therapeutics Corp. Forecast, Technical & Fundamental Analysis

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS)... Show more

SLXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SLXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC19.450.45
+2.37%
Healthpeak Properties
FRPT49.860.44
+0.89%
Freshpet
AUC7.86-0.14
-1.75%
ATIF Holdings Limited.
AQST3.92-0.07
-1.87%
Aquestive Therapeutics
TRUG1.62-0.12
-6.90%
TruGolf Holdings Inc.

SLXN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.20%
IMA - SLXN
62%
Loosely correlated
-0.37%
CELC - SLXN
50%
Loosely correlated
-25.66%
REVB - SLXN
48%
Loosely correlated
-2.75%
CDT - SLXN
44%
Loosely correlated
-5.61%
IMVT - SLXN
42%
Loosely correlated
-5.90%
More
Silexion Therapeutics (SLXN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com